Erlotinib, Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic Cancer

NCT01010945 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

19

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Pancreatic Cancer

Interventions

DRUG: erlotinib
DRUG: gemcitabine
DRUG: nab-paclitaxel

Sponsor

OSI Pharmaceuticals